Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
The Lancet. Oncology
|
February 2, 2013
Targeting developmental pathways in children with cancer: what price success?
Lia Gore, James DeGregori, Christopher C Porter
Seminars in Oncology
|
December 19, 2007
Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?
Lia Gore, Matthias Stelljes, Mattias Stelljes, et al.
Integrated Blood Pressure Control
|
January 27, 2022
Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management Strategies
Lindsey Murphy, Kelly Maloney, Lia Gore, et al.
Journal of Pediatric Hematology/Oncology
|
April 27, 2013
Pulmonary presentation of relapsed acute myeloid leukemia
Lindsey M Hoffman, Lia Gore, Kelly W Maloney
Clinical Pharmacology and Therapeutics
|
March 17, 2025
Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure-Response Analysis
Xiaofei Zhou, Diane R Mould, Lia Gore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates
Julie Kanter, Samina Y Khan, Marguerite Kelher, et al.
Pediatric Blood & Cancer
|
October 6, 2005
Gefitinib is effective against juvenile pilocytic astrocytoma in vitro
Nicholas K Foreman, Lia Gore, Daniel Wells, et al.
Haematologica
|
August 2, 2014
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials
Daniel A Pollyea, Jonathan A Gutman, Lia Gore, et al.
British Journal of Haematology
|
June 14, 2016
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignancies
Farrukh T Awan, Lia Gore, Lei Gao, et al.
Current Oncology Reports
|
October 22, 2008
Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials
Margaret E Macy, Kelly K Sawczyn, Timothy P Garrington, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
The Lancet. Oncology
|
February 2, 2013
Targeting developmental pathways in children with cancer: what price success?
Lia Gore, James DeGregori, Christopher C Porter
Seminars in Oncology
|
December 19, 2007
Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?
Lia Gore, Matthias Stelljes, Mattias Stelljes, et al.
Integrated Blood Pressure Control
|
January 27, 2022
Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management Strategies
Lindsey Murphy, Kelly Maloney, Lia Gore, et al.
Journal of Pediatric Hematology/Oncology
|
April 27, 2013
Pulmonary presentation of relapsed acute myeloid leukemia
Lindsey M Hoffman, Lia Gore, Kelly W Maloney
Clinical Pharmacology and Therapeutics
|
March 17, 2025
Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure-Response Analysis
Xiaofei Zhou, Diane R Mould, Lia Gore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates
Julie Kanter, Samina Y Khan, Marguerite Kelher, et al.
Pediatric Blood & Cancer
|
October 6, 2005
Gefitinib is effective against juvenile pilocytic astrocytoma in vitro
Nicholas K Foreman, Lia Gore, Daniel Wells, et al.
Haematologica
|
August 2, 2014
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials
Daniel A Pollyea, Jonathan A Gutman, Lia Gore, et al.
British Journal of Haematology
|
June 14, 2016
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignancies
Farrukh T Awan, Lia Gore, Lei Gao, et al.
Current Oncology Reports
|
October 22, 2008
Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials
Margaret E Macy, Kelly K Sawczyn, Timothy P Garrington, et al.
Page
of 12